NEOLA Stock Overview
Together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Neola Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 2.55 |
| 52 Week High | SEK 3.78 |
| 52 Week Low | SEK 1.87 |
| Beta | 1 |
| 1 Month Change | 2.00% |
| 3 Month Change | 8.05% |
| 1 Year Change | 30.77% |
| 3 Year Change | -3.04% |
| 5 Year Change | n/a |
| Change since IPO | -61.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| NEOLA | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 4.5% | -0.7% | -2.0% |
| 1Y | 30.8% | -14.0% | -4.4% |
Return vs Industry: NEOLA exceeded the Swedish Medical Equipment industry which returned -14.1% over the past year.
Return vs Market: NEOLA exceeded the Swedish Market which returned -4.9% over the past year.
Price Volatility
| NEOLA volatility | |
|---|---|
| NEOLA Average Weekly Movement | 7.8% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in SE Market | 13.5% |
| 10% least volatile stocks in SE Market | 4.2% |
Stable Share Price: NEOLA has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: NEOLA's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 8 | Hanna Sjostrom | www.neolamedical.com |
Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. The company was formerly known as GPX Medical AB and changed its name to Neola Medical AB (publ) in June 2022.
Neola Medical AB (publ) Fundamentals Summary
| NEOLA fundamental statistics | |
|---|---|
| Market cap | SEK 198.77m |
| Earnings (TTM) | -SEK 10.38m |
| Revenue (TTM) | SEK 8.83m |
Is NEOLA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NEOLA income statement (TTM) | |
|---|---|
| Revenue | SEK 8.83m |
| Cost of Revenue | SEK 705.00k |
| Gross Profit | SEK 8.13m |
| Other Expenses | SEK 18.51m |
| Earnings | -SEK 10.38m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 25, 2025
| Earnings per share (EPS) | -0.13 |
| Gross Margin | 92.02% |
| Net Profit Margin | -117.59% |
| Debt/Equity Ratio | 0% |
How did NEOLA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/27 06:26 |
| End of Day Share Price | 2025/05/27 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Neola Medical AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gustaf Meyer | Redeye |